Top News

• Generex Biotechnology Announces That FDA has Accepted the Pre-IND Briefing Package for the Company’s Ii-Key-SARS-CoV-2 Vaccine and Will Provide a Written Response by August 24, 2020

  Friday, July 31, 2020 · Generex Biotechnology Corporation

• DECN Readies its GenViro! Covid-19 Swift Kits for Latest FDA Mandated Testing of both Saliva and Blood Protocols as it Enters Final Selection Process for a U.S. Based Testing Partner

  Thursday, July 30, 2020 · Decision Diagnostics Corp.

• Q BioMed To Scale Up Production Of Uttroside-B, A Novel Chemotherapeutic For Liver Cancer, In Preparation For IND Filing

  · Q BioMed, Inc.

• Guided Therapeutics Submits Clinical Study Protocol to U.S. FDA for LuViva® Advanced Cervical Scan

  Tuesday, July 28, 2020 · Guided Therapeutics, Inc.

• Generex Biotechnology Announces That FDA has Accepted the Pre-IND Briefing Package for the Company’s Ii-Key-SARS-CoV-2 Vaccine and Will Provide a Written Response by August 24, 2020

  Monday, July 27, 2020 · Generex Biotechnology Corporation